Fulcrum Therapeutics, Inc. (FULC) Form 10-K Annual Reports
Fulcrum Therapeutics, Inc. (FULC) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: FULC
CIK: 1680581
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Ernst & Young LLP
Auditor SinceSince 12/31/2018 12:00:00 AM
Lead Engagement PartnerSteven Connors
Audit LocationBoston, Massachusetts, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| S-4/A | 2026-10-08 | — | S-4/A | 0001193125-26-418056 | View SEC Doc Filr Page |
| 144 | 2026-09-02 | — | 144 Filing | 0001193125-26-379476 | View SEC Doc Filr Page |
| S-4 | 2026-09-02 | — | S-4 | 0001193125-26-379106 | View SEC Doc Filr Page |
| 425 | 2026-08-17 | — | 425 | 0001193125-26-354107 | View SEC Doc Filr Page |
| 425 | 2026-08-17 | — | 425 | 0001193125-26-353282 | View SEC Doc Filr Page |
| 425 | 2026-08-17 | — | 425 | 0001193125-26-353280 | View SEC Doc Filr Page |
| 8-K | 2026-08-17 | 2026-08-16 | 8-K | 0001193125-26-353278 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0001231919-26-000923 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-08-14 | — | SCHEDULE 13G Filing | 0001104659-26-097278 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0000919574-26-005528 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0001193125-26-352345 | View SEC Doc Filr Page |
| 8-K | 2026-08-10 | 2026-08-07 | 8-K | 0001193125-26-341385 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-08-03 | — | SCHEDULE 13G Filing | 0000070858-26-000396 | View SEC Doc Filr Page |
| 10-Q | 2026-07-30 | 2026-06-30 | 10-Q | 0001193125-26-326098 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-07-28 | — | SCHEDULE 13G/A Filing | 0002012383-26-002576 | View SEC Doc Filr Page |
| 4 | 2026-07-20 | 2026-07-16 | 4 Filing | 0001178579-26-000016 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-07-17 | — | SCHEDULE 13G Filing | 0002052113-26-000745 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-07-15 | — | SCHEDULE 13G/A Filing | 0001214659-26-008613 | View SEC Doc Filr Page |
| 4 | 2026-07-15 | 2026-07-13 | 4 Filing | 0001178579-26-000014 | View SEC Doc Filr Page |
| 3 | 2026-07-15 | 2026-07-13 | 3 Filing | 0001178579-26-000013 | View SEC Doc Filr Page |
| 4 | 2026-07-02 | 2026-06-30 | 4 | 0001193125-26-294703 | View SEC Doc Filr Page |
| 4 | 2026-07-02 | 2026-06-30 | 4 | 0001193125-26-294699 | View SEC Doc Filr Page |
| 4 | 2026-07-02 | 2026-06-30 | 4 | 0001193125-26-294697 | View SEC Doc Filr Page |
| 4 | 2026-07-02 | 2026-06-30 | 4 | 0001193125-26-294692 | View SEC Doc Filr Page |
| 4 | 2026-07-02 | 2026-06-30 | 4 | 0001193125-26-294691 | View SEC Doc Filr Page |